Exelixis (EXEL) Capital Expenditures (2010 - 2026)

Exelixis' (EXEL) quarterly Capital Expenditures came in at $1.5 million in Q2 2026, down 48.88% year-on-year from $3.0 million in Q2 2025, and up 30.42% quarter-over-quarter from $1.2 million in Q1 2026.

Exelixis (EXEL) Capital Expenditures (2010 - 2026) Analysis & Trends

Exelixis' Capital Expenditures history runs 17 years deep, the most recent figure standing at $1.5 million for Q2 2026.

  • On a quarterly basis, Capital Expenditures fell 48.88% year-over-year to $1.5 million in Q2 2026; TTM through Apr 2026 was $7.0 million, a 67.8% decrease from a year earlier, with the FY2026 full-year figure at $8.4 million, down 70.36% from the prior year.
  • Capital Expenditures advanced to $1.5 million in Q2 2026 per EXEL's latest filing, from $1.2 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $13.1 million in Q4 2023 and bottomed at $1.2 million in Q1 2026.
  • The 5-year median for Capital Expenditures is $5.9 million (2023), against an average of $6.3 million.
  • Across the five-year window, Capital Expenditures surged 117.62% in 2022 and sank 81.92% in 2025, its largest moves.
  • Year by year, Capital Expenditures stood at $9.7 million in 2022, then soared by 35.18% to $13.1 million in 2023, then plunged by 37.59% to $8.2 million in 2024, then sank by 81.92% to $1.5 million in 2025, then gained by 1.82% to $1.5 million in 2026.
  • Per Business Quant, the three latest EXEL Capital Expenditures figures stand at $1.5 million (Q2 2026), $1.2 million (Q1 2026), and $1.5 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -8,939.03
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 43.25 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 133.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 230.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 786,000.00
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn 1.51 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 1.51 Mn
Apr 3, 2026 1.51 Mn
Jan 2, 2026 1.16 Mn
Jan 2, 2026 1.16 Mn
Oct 3, 2025 1.48 Mn
Oct 3, 2025 1.48 Mn
Jul 4, 2025 2.84 Mn
Jul 4, 2025 2.84 Mn
Apr 4, 2025 2.95 Mn
Apr 4, 2025 2.95 Mn
Jan 3, 2025 3.98 Mn
Jan 3, 2025 3.98 Mn
Sep 27, 2024 8.20 Mn
Sep 27, 2024 8.20 Mn
Jun 28, 2024 6.57 Mn
Jun 28, 2024 6.57 Mn
Mar 29, 2024 9.69 Mn
Mar 29, 2024 9.69 Mn
Dec 29, 2023 13.14 Mn
Dec 29, 2023 13.14 Mn